Gulf Coast TX
US FDA Approves Prestige Biopharma's IND for Phase 1/2a Trial of First-in-Class Pancreatic Cancer Treatment, PBP1510
SINGAPORE--(BUSINESS WIRE)--Jun 27, 2022-- |!| Rosenberg
More from Gulf Coast
KSEV Radio Houston
Wall St futures climb as AI stocks rebound; oil, yields fall
Gulf Coast
•
22m ago
KSEV Radio Houston
Lee says S Korea capable of taking back wartime command of combined US forces
Gulf Coast
•
22m ago
KSEV Radio Houston
JPMorgan announces $5 billion in investments in companies critical to US national security
Gulf Coast
•
22m ago
KSEV Radio Houston
Two Serbian opposition figures targeted with spyware, research group says
Gulf Coast
•
22m ago
KSEV Radio Houston
Albertsons begins its $8 billion trial against Kroger over failed merger
Gulf Coast
•
22m ago
KSEV Radio Houston
Exclusive-How one hacker used AI agents and a few thousand dollars to break into scores of sites
Gulf Coast
•
22m ago
KSEV Radio Houston
Alberta votes on leaving Canada; separatist movement likely to outlast expected defeat
Gulf Coast
•
22m ago